LATEST ARTICLES
United States
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
This is part of a series of articles discussing recent orders of interest issued in IP cases by the United States District Courts in the Southeast.
Wolf, Greenfield & Sacks, P.C.
The Bayh-Dole Act ("Bayh-Dole") governs the rights to inventions made with federal assistance. It offers ownership rights to federal award recipients...
Gray Reed & McGraw LLP
Intellectual property ("IP") development can cost millions of dollars so cost recovery timing can be financially material.
Seyfarth Shaw LLP
The United States Patent and Trademark Office (USPTO) has proposed significant changes to patent fee structures for the 2025 fiscal year.
Wolf, Greenfield & Sacks, P.C.
Use of AI-based tools are permitted, but parties should use caution to ensure compliance with all duties and obligations...
Jones Day
In denying inter partes review in OBM, Inc. & Cholla Energy LLC v. Lancium LLC, the PTAB again made clear that "technical availability" of a reference is not enough to establish ...
Jones Day
On March 7, 2024, the PTAB denied institution in 10x Genomics, Inc. v. President and Fellows of Harvard College, IPR2023-01299, Paper 15 (PTAB Mar. 7, 2024) ("Decision").
Crowell & Moring LLP
On April 10, 2024, the U.S. House of Representatives, Judiciary Committee Subcommittee on Intellectual Property convened Part III to an ongoing discussion and exploration of artificial intelligence...
Axinn Veltrop & Harkrider
Among the most established standards in patent law is that obviousness requires a motivation to combine the prior art with "a reasonable expectation of success."
Osha Bergman Watanabe & Burton LLP
On February 13, 2024, the USPTO published its much-anticipated guidance on inventorship for AI-assisted inventions with immediate effect.
Foley & Lardner
Arecent report from patent data powerhouse RPX Corp. shows that inter partes review (IPR) filings have increased significantly over the last three quarters, pointing to increased litigation over the last year...
Oblon, McClelland, Maier & Neustadt, L.L.P
Effective March 29, 2024, the U.S. Patent and Trademark Office (USPTO) issued a final rule to revise 37 C.F.R. §§ 90.2, 90.3, and 2.145 by updating how the following documents are to be filed with the USPTO Director...
Harness IP
We've all seen it. Patent attorneys love making up words. For example, instead of claiming a pipe, a hose, or a tube, we draft patent claims reciting "a fluid delivery system" or "a fluid conduit."
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
If a US patent maintenance fee has not been paid in a timely manner and the owner of the patent wants to get the patent rights reinstated...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The First-Time Filer Expedited Examination Pilot Program, implemented by the U.S. Patent and Trademark Office (USPTO) and its Council for Inclusive Innovation (CI2)...
Goodwin Procter LLP
On April 5, the FDA granted accelerated approval to AstraZeneca and Daiichi Sankyo's ENHERTU (trastuzumab deruxtecan) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options.
Jones Day
Director Vidal recently vacated the Patent Trial and Appeal Board's (PTAB) decision to deny institution of three petitions for inter partes review (IPR), citing insufficient explanation...
Sheppard Mullin Richter & Hampton
This case addresses whether the district court's grant of summary judgment was proper based on the district court's finding that the asserted claims of U.S. Patent No. 8,197,807 ("the '807 patent") were invalid under 35 U.S.C. § 101 for being directed to a natural phenomenon.
Goodwin Procter LLP
On April 1, 2024, the Federal Circuit released its opinion in Janssen Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals USA, Inc. et al., affirming the district court's finding that certain claims were not indefinite and remanding to the district court to reevaluate its obviousness decision.
Axinn Veltrop & Harkrider
Much like secondary considerations, non-infringing alternatives fit imperfectly within many scheduling orders. The patentee has the burden of proof on damages...
Mondaq Webinars
APR24
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Comparative Guides
Curated Content
Parallel Imports, A Global Phenomenon, And A Very Grey Area Regarding International Trade
Braumiller Law Group, PLLC
Braumiller Law Group, PLLC
Popular Contributors
Ankura Consulting Group LLC
United States
Torres Trade Law, PLLC
United States
MoginRubin
United States
Upcoming Events
APR23
Webinar Boston United States
APR23
Seminar San Jose United States
Mondaq Advice Centres
